Korea, Democratic People's Republic of (the)

in page functions
[French]
DPR Korea
Total population (2019) 25,646,043
Birth cohort (2019) 362,374
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 20/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 25/1000
No. of districts/territories (2018) 210

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for DPR Korea

Type of support

Approvals

2001-2023 (US$)
(17 Sep 2019)

Commitments

2001-2023 (US$)
(17 Sep 2019)

Disbursements

2000-2019 (US$)
(17 Sep 2019)

% Disbursed

(17 Sep 2019)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $81,527,585 $82,980,585 $66,338,951
Health system strengthening (HSS 1) $4,360,000 $4,360,000 $4,360,000 100%
Health system strengthening (HSS 2) $36,554,748 $36,554,748 $23,981,011 66%
HepB mono (NVS) $2,043,505 $2,043,505 $2,043,505 100%
Immunisation services support (ISS) $2,222,971 $2,222,971 $2,222,971 100%
Injection Safety Devices (NVS) $571,465 $672,965 $525,611 92%
Injection safety support (INS) $743,726 $743,726 $743,726 100%
IPV (NVS) $2,810,031 $2,810,031 $2,819,894 100%
Measles (NVS) $938,383 $938,383 $982,252 105%
MR 1st and 2nd dose (NVS) $87,000 $416,500 $89,114 102%
MR-Catch-up campaign (NVS) $4,861,000 $4,861,000 $4,987,630 103%
MR-Catch-up campaign op.costs (OPC) $4,371,872 $4,371,872
Penta (NVS) $14,512,547 $15,534,547 $16,422,348 113%
Tetra DTP-HepB (NVS) $6,552,614 $6,552,614 $6,552,614 100%
Vaccine Introduction Grant (VIG) $897,723 $897,723 $608,275 68%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

DPR Korea DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2018)

Grade of confidence


N/A
DTP3 - Official country estimates (2018) 97%
M:F sex ratio at birth (2019) 1.05
Household survey: Last DTP3 survey (2007) 92%
% districts achieving > 80% DTP3 coverage (2018) 100%
% districts achieving < 50% DTP3 coverage (2018) 0%
MCV WHO/UNICEF estimates (2018) 98%

Breakdown of support

Non-vaccine support Vaccine support
48% 52%
$31,915,983 $34,422,968

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to DPR Korea

18 September 2014

Nepal IPV

Nepal becomes first country to introduce IPV with Gavi support

Nepal is one of 25 countries who have received approval to begin using IPV with Gavi support. Afghanistan and Pakistan are also planning to introduce IPV by end of next year.

03 December 2012

DPR Korea introduces pentavalent vaccine

In July 2012, the Democratic People's Republic of Korea (DPRK) introduced pentavalent vaccine with support from the GAVI Alliance. Children in DPR Korea will benefit from protection against Haemophilus influenzae type b (Hib) disease in addition to continuing protection from four other childhood killers as the country introduces the five-in-one pentavalent vaccine into its routine immunisation programme.

28 November 2012

UNICEF_2009_Bura_Indonesia copyF

02 – Intensification of routine immunisation in South-East Asia

Partners Forum 2012 - Session summary. This session highlighted the efforts being made in SEA countries to implement intensification activities for reaching more children with immunization services.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here